71 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am
. The Board of Directors and the Executive Leadership team remain committed to running a fulsome process that reflects the best interests of the Company
8-K
EX-99.1
yel2v
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
8-K
EX-99.1
dv8btb82j17pj
21 Aug 23
Dr. Daniel G. Billen appointed Chair of the Board of Directors
4:11pm
PX14A6G
lzn8ixpcgx kcz
17 May 23
Letter to shareholders
4:00pm
PX14A6G
qg3g0d5g
5 May 23
Letter to shareholders
11:17am
PX14A6G
qtygjmgv7leki3pv646o
3 May 23
Letter to shareholders
2:53pm
PX14A6G
twu nuv92ws89
26 Apr 23
Letter to shareholders
10:20am
DEFA14A
1baqu28e
18 Apr 22
Additional proxy soliciting materials
7:36am
DEF 14A
ifluz8n8ev 8f
10 May 21
Definitive proxy
4:06pm
PRE 14A
ysxlkis
27 Apr 21
Preliminary proxy
4:32pm
10-K
EX-10.17
un1kc
24 Feb 21
Annual report
4:09pm
10-K
EX-10.6
i9fhk1e5 7v09y
24 Feb 21
Annual report
4:09pm
6-K
EX-99.1
ttbts 224gsjgvra1g9
11 Aug 20
Aurinia Pharmaceuticals Inc. 6-K
4:02pm